ARTICLE | Distillery Therapeutics
Therapeutics: Acetylcholinesterase (AChE); serotonin (5-HT4) receptor
April 16, 2015 7:00 AM UTC
Mouse studies suggest a dual AChE inhibitor and partial serotonin (5-HT4) receptor agonist could help treat AD. Chemical synthesis and in vitro testing identified the small molecule donecopride that i...